LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Radicicol | 0.37 | uM | LJP5 | 72 | hr | 868 | 1485 | 3410 | 0.4356 | 0.3123 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 868 | 1679 | 3556 | 0.4724 | 0.3830 |
MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 72 | hr | 868 | 1146 | 3410 | 0.3359 | 0.1501 |
MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 72 | hr | 868 | 1277 | 3556 | 0.3591 | 0.2086 |
MDA-MB-231 | Radicicol | 3.33 | uM | LJP5 | 72 | hr | 868 | 1112 | 3410 | 0.3254 | 0.1305 |
MDA-MB-231 | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 868 | 1277 | 3556 | 0.3593 | 0.2090 |
MDA-MB-231 | Radicicol | 10 | uM | LJP5 | 72 | hr | 868 | 1020 | 3410 | 0.2993 | 0.0850 |
MDA-MB-231 | Radicicol | 10 | uM | LJP6 | 72 | hr | 868 | 1066 | 3556 | 0.2997 | 0.1058 |
MDA-MB-231 | Withaferin A | 0.04 | uM | LJP5 | 72 | hr | 868 | 3875 | 3410 | 1.1376 | 1.1350 |
MDA-MB-231 | Withaferin A | 0.04 | uM | LJP6 | 72 | hr | 868 | 3607 | 3556 | 1.0158 | 1.0156 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP5 | 72 | hr | 868 | 3622 | 3410 | 1.0627 | 1.0630 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP6 | 72 | hr | 868 | 3540 | 3556 | 0.9964 | 0.9967 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP5 | 72 | hr | 868 | 2200 | 3410 | 0.6460 | 0.6025 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP6 | 72 | hr | 868 | 1918 | 3556 | 0.5393 | 0.4761 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 72 | hr | 868 | 936 | 3410 | 0.2750 | 0.0386 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 72 | hr | 868 | 807 | 3556 | 0.2274 | -0.0348 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 868 | 768 | 3410 | 0.2261 | -0.0638 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 868 | 675 | 3556 | 0.1899 | -0.1183 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP5 | 72 | hr | 868 | 476 | 3410 | 0.1396 | -0.2634 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP6 | 72 | hr | 868 | 532 | 3556 | 0.1501 | -0.2141 |
BT-20 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5718 | 5588 | 1.0234 | 1.0266 |
BT-20 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5585 | 5588 | 0.9996 | 0.9994 |
BT-20 | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5212 | 5588 | 0.9328 | 0.9221 |
BT-20 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4763 | 5588 | 0.8525 | 0.8258 |
BT-20 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4547 | 5588 | 0.8139 | 0.7783 |